Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study | The Lancet | published 28th May 2020
Data on patients with COVID-19 who have cancer are lacking. In this article, the authors characterise the outcomes of a cohort of patients with cancer and COVID-19 and identify potential prognostic factors for mortality and severe illness.
The research found that among patients with cancer and COVID-19, 30-day all-cause mortality was high and associated with general risk factors and risk factors unique to patients with cancer. Longer follow-up is needed to better understand the effect of COVID-19 on outcomes in patients with cancer, including the ability to continue specific cancer treatments.
Full article: Clinical impact of COVID-19 on patients with cancer